Targeting stents with local delivery of paclitaxel-loaded magnetic nanoparticles using uniform fields. - Wikidata - wikimedia - TriplyDB

Targeting stents with local delivery of paclitaxel-loaded magnetic nanoparticles using uniform fields.

Targeting stents with local delivery of paclitaxel-loaded magnetic nanoparticles using uniform fields.

http://www.wikidata.org/entity/Q33929284

about

Bioresponsive matrices in drug delivery Enabling anticancer therapeutics by nanoparticle carriers: the delivery of Paclitaxel Force dependent internalization of magnetic nanoparticles results in highly loaded endothelial cells for use as potential therapy delivery vectors Nanotechnology in diagnosis and treatment of coronary artery disease.Perspectives and opportunities for nanomedicine in the management of atherosclerosis.Dextran coated bismuth-iron oxide nanohybrid contrast agents for computed tomography and magnetic resonance imaging.In vivo prevention of arterial restenosis with paclitaxel-encapsulated targeted lipid-polymeric nanoparticles Nanomedical Theranostics in Cardiovascular Disease.Delivery of Polymeric Nanoparticles to Target Vascular Diseases.Endovascular Gene Delivery from a Stent Platform: Gene- Eluting Stents.Magnetic nanoparticles and nanocomposites for remote controlled therapies.Ferromagnetic Bare Metal Stent for Endothelial Cell Capture and Retention.Magnetically enhanced cell delivery for accelerating recovery of the endothelium in injured arteries.Magnetic nanoparticle-based approaches to locally target therapy and enhance tissue regeneration in vivo Site-specific gene delivery to stented arteries using magnetically guided zinc oleate-based nanoparticles loaded with adenoviral vectors Vascular Inflammation: A Novel Access Route for Nanomedicine Nanoparticle drug- and gene-eluting stents for the prevention and treatment of coronary restenosis.Drug- and Gene-eluting Stents for Preventing Coronary Restenosis.Computational modeling of magnetic nanoparticle targeting to stent surface under high gradient field.Real-time analysis of composite magnetic nanoparticle disassembly in vascular cells and biomimetic media.Nanotechnology for the treatment of coronary in stent restenosis: a clinical perspective.Magnetic nanoparticles for targeted vascular delivery.Nanotechnology in interventional cardiology.Restenosis after PCI. Part 2: prevention and therapy.Magnetic nanoparticles: an update of application for drug delivery and possible toxic effects.Biological applications of magnetic nanoparticles.Magnetically targeted delivery of therapeutic agents to injured blood vessels for prevention of in-stent restenosis.Nanomedicine in cardiovascular therapy: recent advancements.Surface chemical and physical modification in stent technology for the treatment of coronary artery disease.Advances in nanotechnology for the management of coronary artery disease.Role of biomaterials in prevention of in-stent restenosis.Nanocarriers for vascular delivery of anti-inflammatory agents Therapeutic magnetic microcarriers guided by magnetic resonance navigation for enhanced liver chemoembilization: a design review.Stimuli responsive upconversion luminescence nanomaterials and films for various applications.Next-generation nanoantibacterial tools developed from peptides.Progress and prospects of endothelial progenitor cell therapy in coronary stent implantation.Emerging translational research on magnetic nanoparticles for regenerative medicine.Optimizing endothelial cell functionalization for cell therapy of vascular proliferative disease using a direct contact co-culture system.Nanomedicine in coronary artery disease.Magnetic field enhanced cell uptake efficiency of magnetic silica mesoporous nanoparticles.

P2860

Q24629097-1E32210F-B223-412A-B29E-E58BA29B2DEB Q26999288-C546AAE3-5523-4128-98EC-8CA2040F0E02 Q28396268-DEF626BB-DE4F-4E3B-99F4-8DE10F3802E5 Q30362371-4DF037AA-2DD0-4D01-8493-353032811FF0 Q30455490-8D229874-B82B-434A-88E1-8BCBC102262B Q34609644-57942C02-A3B2-4261-A210-AC5F1CBFFCDC Q35585791-461447E7-423F-48FD-8D0F-313AFA0F41A1 Q35681183-B62D026D-F1E5-4FB5-9AA9-BA57490BC645 Q35701214-41363311-A0B7-480A-83CC-4F6689FDA40B Q35893044-5589805E-8FB0-4BA0-A94A-FE6E971B4FA2 Q36345256-E58FE3FD-14A0-401E-89F2-18B7C87502F5 Q36408215-1149CEBA-3A42-45A1-931A-5A4610A0053A Q36479606-15F0CD1F-8C10-4F75-B7F0-21450EE4C396 Q36528148-15654A37-5136-41B1-B1BA-9063302FFF9B Q36860331-807CA8E8-6505-47F2-AD8F-B60F47A88156 Q37397963-DB645BF5-7692-490C-B4E9-2EF2E6823BB0 Q37511128-128F6BD2-3496-4652-89A4-FE560A9BD634 Q37633078-A6EFA3B6-E405-4F99-B1F7-CCAF7B801C91 Q37640710-FDB69898-C8DD-4489-A92F-D1416C0C5E0D Q37659934-B3708AA0-8868-4C95-98F9-68457C9290B8 Q37866394-B5875CC1-F4EB-4173-BA98-EEDF439CAC36 Q37896554-49A0222C-7EF7-4012-8DA3-8536A64D6044 Q37900267-B5F01B56-2A1B-412C-AE78-5C9709969E6F Q37944416-F604DD5C-5E24-4CBF-87C1-56CD21360996 Q37955034-12C620C6-46AC-49F1-ABD5-7BA56B4BF657 Q38000520-E27158DB-52F4-4115-9148-6DC240604D76 Q38034502-1E179809-0A63-41A7-BFFE-0A4E118231AA Q38034812-1F32BA69-459F-4CFF-872A-48BA2BAB9A0B Q38040738-720D909F-31A7-466A-900C-232B34F16A01 Q38067933-CA11EDC3-219A-4D6B-9140-E4A7C243ED92 Q38168808-510809A9-17B8-4BC6-B67B-068C56DEB910 Q38176037-F01DB42B-862E-4CF3-9364-2BB41B82A504 Q38179297-72E983E8-28B0-475A-A484-F6815BDA41D8 Q38247007-15C4C8AD-9E45-4169-9796-CABF1B915CC1 Q38501669-4398B404-543E-4503-AF8D-71942E5F00D7 Q38522829-FCD6B977-47C1-43A0-8A36-75BE598E2724 Q38617021-ADA3A2BB-97F6-4F71-9DDD-E32BB9FE0E15 Q38696169-82477A57-7398-4CDE-8B5E-4AA52CE339F3 Q39276023-3CDEE91C-CD40-44DE-8362-79D8CB3726EE Q39356855-D4AEC9AF-47B0-4F37-93AC-EFD79D4C248D

P2860

Targeting stents with local delivery of paclitaxel-loaded magnetic nanoparticles using uniform fields.

http://www.wikidata.org/entity/Q33929284

description

2010 nî lūn-bûn

@nan

2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Targeting stents with local de ...... articles using uniform fields.

@ast

Targeting stents with local de ...... articles using uniform fields.

@en

type

label

Targeting stents with local de ...... articles using uniform fields.

@ast

Targeting stents with local de ...... articles using uniform fields.

@en

prefLabel

Targeting stents with local de ...... articles using uniform fields.

@ast

Targeting stents with local de ...... articles using uniform fields.

@en

P1433

Q33929284-B2B9F637-63B9-4AB1-80F6-46D3B2E04F04

P1476

Q33929284-398CBBB5-1BA8-4F04-A28B-3A3E958AC2DA

P2093

Q33929284-4573A2BF-7B23-4BC6-A3C2-F9A8D6D9BA1F

Q33929284-5A68E1C6-4F76-47D6-A7A0-D26EE751EAEB

Q33929284-5DABA233-C725-4416-BDAB-B016E1E73A68

Q33929284-725E9014-75A3-4B0C-BFD1-36BB91B77699

Q33929284-7B9A6C14-287A-4080-A849-CA3C443164F7

Q33929284-C7FA9D74-269F-4BB5-A581-2C47B641FC14

Q33929284-C83704AE-6117-4B83-822D-704A9A89544D

Q33929284-C9556E24-C2C4-472C-B59C-330E8A2723C8

Q33929284-F90C2E08-191A-42B5-BA3D-24447E969609

Q33929284-FF7ECE47-BC0A-4F8D-8FA5-944E1B276C6A

P2860

Q33929284-005D82F1-ECA3-4693-80EB-58E3B4FCA8B1

Q33929284-0461895E-A2FC-496B-B6B7-FFB63DC7007B

Q33929284-0B8B1D10-A05B-4096-BD76-26FC60E3C6B0

Q33929284-1E4D00C2-757F-4141-9756-61A25E3B25D7

Q33929284-3D0C9262-50BC-4C11-8899-0A919143EAB5

Q33929284-6493D099-02F3-47F4-9A29-DF3C2A3BC26E

Q33929284-6B7718FF-BD6A-4F88-B183-B2C29BB92887

Q33929284-7132BF98-C07C-4A1A-8441-8C21CB00C69B

Q33929284-786809D1-F4BF-4CB9-AC2F-F25D328C9A71

Q33929284-7A90C706-CAF0-440D-9C57-C53D14AC6481

P304

Q33929284-581450B3-45C8-414F-A8B7-24CA15778817

P31

Q33929284-E048D6EC-49C3-4DE4-9412-426599E9EA6A

P356

Q33929284-3297DDCD-6E9E-4B0C-98AC-EBEF6A94E4A2

P407

Q33929284-EBADEB15-D690-425D-B9D4-9C53DFB389EC

P433

Q33929284-9150CC20-AF06-4060-9E3A-5912380D9246

P478

Q33929284-FE8E7736-6F43-4109-9F06-BC35EC5F6B9A

P577

Q33929284-0E831FFE-D590-43B3-8113-BB02CED86D8D

P5875

Q33929284-B7ACDCBB-49DB-4C26-8714-6D59669BD125

P698

Q33929284-3671BB32-BF97-420E-95FE-BFA20DCF08EF

P921

Q33929284-61C78DE6-706D-4514-AB2F-998FA7281207

Q33929284-F61AC413-F825-4382-A5AC-8A3ABB0B6230

P932

Q33929284-DDA46E03-1BD4-4C53-A7EB-50C03B360185

P356

PNAS.0909506107

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Targeting stents with local de ...... articles using uniform fields.

@en

P2093

Benjamin B Yellen

http://www.w3.org/2001/XMLSchema#string

Gary Friedman

http://www.w3.org/2001/XMLSchema#string

Ilia Fishbein

http://www.w3.org/2001/XMLSchema#string

Ivan S Alferiev

http://www.w3.org/2001/XMLSchema#string

Mansoor Amiji

http://www.w3.org/2001/XMLSchema#string

Marina Bakay

http://www.w3.org/2001/XMLSchema#string

Michael Chorny

http://www.w3.org/2001/XMLSchema#string

Richard Adamo

http://www.w3.org/2001/XMLSchema#string

Robert J Levy

http://www.w3.org/2001/XMLSchema#string

Srinivas Ganta

http://www.w3.org/2001/XMLSchema#string

P2860

Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions

Determination of paclitaxel in human and rat blood samples after administration of low dose paclitaxel by HPLC-UV detection.

Bisphosphonate-mediated gene vector delivery from the metal surfaces of stents.

Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial.

Early experiences and clinical implications of drug-eluting stents: part 1.

High field gradient targeting of magnetic nanoparticle-loaded endothelial cells to the surfaces of steel stents.

Adsorption/desorption of human serum albumin at the surface of poly(lactic acid) nanoparticles prepared by a solvent evaporation process.

Coronary stent healing, endothelialisation and the role of co-medication

Sirolimus-eluting versus bare-metal low-profile stent for renal artery treatment (GREAT Trial): angiographic follow-up after 6 months and clinical outcome up to 2 years.

In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy.

P304

8346-8351

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0909506107

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

107

http://www.w3.org/2001/XMLSchema#string

P577

2010-04-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

43201545

http://www.w3.org/2001/XMLSchema#string

P698

20404175

http://www.w3.org/2001/XMLSchema#string

P921

magnetic nanoparticles

P932

2889533

http://www.w3.org/2001/XMLSchema#string